Related Experiment Video
Updated: Jun 20, 2025

04:45
Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
Published on: May 10, 2021
3.7K
Intraoperative technologies to assess margin status during radical prostatectomy - a narrative review
O Windisch1,2, M Diana3, D Tilki4,5,6
1Service of Urology, Department of Surgery, Geneva University Hospitals, Genève, Switzerland. o.windisch@gmail.com.
Prostate Cancer and Prostatic Diseases
|July 18, 2024
Summary
Positive surgical margins (PSM) in prostate cancer surgery increase recurrence risk. New intraoperative techniques, including advanced imaging and frozen section analysis, aim to reduce PSM rates and improve nerve-sparing surgery outcomes.
Area of Science:
- Urology
- Surgical Oncology
- Medical Imaging
Background:
- Positive surgical margin (PSM) is a significant concern in radical prostatectomy for prostate cancer (PCa), linked to higher recurrence rates and need for further treatments.
- Current strategies like multiparametric MRI (mpMRI) and fusion biopsy help, but cannot always prevent PSM due to limitations in imaging and surgical dissection.
Purpose of the Study:
- To review established and emerging intraoperative techniques for assessing positive surgical margins (PSM) during radical prostatectomy.
- To highlight advancements aimed at reducing PSM rates and improving nerve-sparing surgical outcomes.
Main Methods:
- Review of established intraoperative frozen section techniques, specifically neurovascular structure-adjacent frozen section examination (NeuroSAFE).
- Exploration of novel ex vivo (fluorescent confocal microscopy, intraoperative PET-CT) and in vivo (augmented reality, PSMA-fluorescent guided surgery) technologies for PSM assessment.
- Discussion of the advantages and limitations of each technique.
Main Results:
- NeuroSAFE technique effectively reduces PSM rates and supports nerve-sparing surgery but faces barriers in accessibility, cost, and time.
- Emerging ex vivo and in vivo technologies offer potential solutions for real-time, intraoperative PSM assessment with varying logistical demands.
- In vivo technologies provide intracorporeal analysis, enhancing surgical precision.
Conclusions:
- Continuous innovation in intraoperative assessment techniques is crucial for minimizing PSM in prostate cancer surgery.
- New technologies promise to overcome limitations of current methods, potentially making PSM assessment more accessible and efficient.
- Further development and validation of these advanced techniques are essential for widespread clinical adoption and improved patient outcomes.

